AINPF:OTC-Ain Holdings Inc (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 64.70

Change

0.00 (0.00)%

Market Cap

USD 2.63B

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Ain Holdings Inc. engages in the dispensing pharmacy, and drug and cosmetic store businesses primarily in Japan. Its Dispensing Pharmacy segment operates dispensing pharmacies; sells generic drugs; and provides staff dispatching and introduction services, as well as consulting services. The company's Cosmetic and Drug Store segment manages cosmetic and drug stores under the ainz & tulpe brand. Its Other segment is involved in real estate rental business. As of July 31, 2018, the company operated 1,024 dispensing pharmacies, and 48 drug and cosmetic stores. The company was formerly known as Ain Pharmaciez Inc. and changed its name to Ain Holdings Inc. in November 2015. Ain Holdings Inc. was founded in 1969 and is headquartered in Sapporo, Japan.

Currency: USD

Country : USA

Technical Indicators

Beta : -0.24

52 Week High : 74.11

52 Week Low : 74.11

200 Day Moving Average : 73.85

50 Day Moving Average : 74.11

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-01 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BTHI Big Time Holdings, Inc

N/A

 USD151.65B N/A N/A
HENOF Henkel AG & Co. KGaA

N/A

 USD44.00B 15.83 N/A
SEMHF Siemens Healthineers AG

N/A

 USD43.74B 30.16 N/A
DFIFF Diamond Fields Resources Inc

+0.02 (+22.67%)

 USD43.14B 39.43 N/A
YACAF Yancoal Australia Ltd

N/A

 USD41.57B 0.20 N/A
HDALF Haidilao International Holding..

N/A

 USD37.30B 79.20 N/A
MQBKY Macquarie Group Limited

+2.06 (+2.02%)

 USD37.00B 22.18 8.17
PETFF PTT Public Company Limited

N/A

 USD34.53B 14.15 0.17
WXIBF WuXi Biologics (Cayman) Inc

N/A

 USD33.35B 593.75 31.62
SARTF Sartorius Aktiengesellschaft

N/A

 USD31.43B 114.64 N/A

ETFs Containing AINPF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification ()		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.63B N/A N/A 76% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.40 N/A N/A 24% F
Price/Book Ratio 26.63 N/A N/A 7% F
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA -89.50 N/A N/A 98% A+
Management Effectiveness  
Return on Equity 9.03% N/A N/A 71% C-
Return on Invested Capital 8.62% N/A N/A 67% D+
Return on Assets 5.36% N/A N/A 86% B
Debt to Equity Ratio 5.76% N/A N/A 73% C
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta -0.24 N/A N/A 87% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.